Novartis AG
Change company Symbol lookup
Select an option...
NVS Novartis AG
FRBA FIRST BANK (Hamilton)
UNM Unum Group
LLY Eli Lilly and Co
BDC Belden Inc
TTM Tata Motors Ltd
HOG Harley-Davidson Inc
SKY Skyline Champion Corp
MMM 3M Co
MPX Marine Products Corp
Go

Health Care : Pharmaceuticals | Large Cap Value
Based in Switzerland
Company profile

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Price
Delayed
$79.02
Day's Change
-1.93 (-2.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
79.72
Day's Low
78.91
Volume
(Heavy Day)

Today's volume of 423,667 shares is on pace to be much greater than NVS's 10-day average volume of 1,640,966 shares.

423,667

Amazon upgraded as analysts forecast the e-commerce giant's staying power even after shoppers return to stores

7:58 am ET September 22, 2020 (MarketWatch)
Print

Tonya Garcia

Amazon.com Inc. shares rose 2% in Tuesday premarket trading after the e-commerce giant was upgraded to outperform from market perform at Bernstein. Analysts maintained their $3,400 price target.

Bernstein forecasts that Amazon (AMZN) will still be the go-to choice for shoppers, even after the pandemic.

"[W]e undervalued the power of being the sole e-commerce demand aggregator," Bernstein wrote in a note.

Read:Amazon launches Luxury Stores, an invitation-only shopping experience for high-end fashion and beauty (https://www.marketwatch.com/story/amazon-launches-luxury-stores-an-invitation-only-shopping-experience-for-high-end-fashion-and-beauty-2020-09-15)

"Amazon is positioned to increase their dominant share position when the return to physical stores occurs. Amazon has also quietly made substantial inroads into grocery and 'shopping' verticals."

Analysts led by Mark Shmulik also have first-hand experience with the benefits of one-day delivery, an offering that they first thought would not be much of a competitive advantage. Analysts say they ended up purchasing a TV and having it installed through services they found on Amazon that were cheaper and quicker than BestBuy.com (BBY) .

"Amid COVID, Amazon has executed incredibly well, pivoting its operations and inventory to in-demand verticals -- with flexibility and speed we didn't expect," analysts said.

And the company can make further gains in other "revenue pools" like advertising and cloud services.

Amazon stock has rallied more than 60% for the year to date. The Amplify Online Retail ETF (IBUY) has gained 67.8%. And the S&P 500 index is up 1.6% for the period.

-Tonya Garcia; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

September 22, 2020 07:58 ET (11:58 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.